A recent study published in Lancet medical journal has shaken up the breast cancer field. Traditionally, in order to prevent recurrences and extend longevity, we have treated early breast cancer patients who have hormone sensitive tumors with 5 years of the hormone blocker Tamoxifen. However, a recent study shows that 10 years of treatment results in …
The post New study suggests that Tamoxifen needs to be taken for 10 years for improved survival. appeared first on Ashikari Breast Center.